Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented ...

Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced ...

Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UC San Francisco study finds that Artificial Intelligence-enhanced ...

Please provide your email address to receive an email when new articles are posted on . Artificial intelligence to assess changes in ECGs may represent a novel method to evaluate disease status and ...

Clinically important arrhythmias, especially nonsustained ventricular tachycardia (NSVT), may be more prevalent in patients with hypertrophic cardiomyopathy (HCM) than widely believed, suggests a ...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how the Viz HCM module enables ...

Patients with hypertrophic cardiomyopathy (HCM) must be assessed using a 24- or 48-hour Holter monitor at least every 2 years to identify atrial fibrillation (AFib) or nonsustained ventricular ...

Researchers at Mount Sinai in New York City say they've developed a new artificial intelligence model designed for electrocardiogram analysis. The innovative AI approach could vastly improve the ...

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition affecting about 1 in 500 people and is one of the leading causes of sudden cardiac death (SCD) in people under 35, including among ...

Even a decade ago, the notion of software as medical device (SAMD) sounded like science fiction. But in 2023, the US Food and Drug Administration cleared the first two algorithms based on artificial ...

The use of 24-48 hour Holter monitoring is recommended to detect atrial fibrillation and NSVT in patients with HCM. 5 Extended ECG monitoring has previously been shown to improve detection of atrial ...